Abstract
An examination of the recent literature suggests that the role of mass spectrometry (MS) in the fields of drug disposition and pharmacokinetics is expanding. This is most likely a consequence of the availability of new instrumentation and ionization techniques that can be used to help solve difficult bioanalytical problems associated with these fields (Burlingame et al. 1990, 1992). This can perhaps be best illustrated in the development of electrospray (ESI) and related atmospheric pressure ionization (API) techniques such as ionspray and atmospheric pressure chemical ionization (APCI) for studies in drug disposition. Over the last 2 years there has been an unprecedented explosion in the use of instrumentation dedicated to Apims (Smith et al. 1990; Fenn et al. 1990; Hamdan and Curcuruto 1991; Huang et al. 1990; Huang and Henion 1991; Bruins 1991; Wachs et al. 1991). Perusal of the literature would suggest that thermospray (TSP) is still the most popular liquid chromatography (LC)/MS technique for structural and quantitative studies (Arpino 1990). However, this is to some extent a reflection of the fact that many APIMS studies have not been reported in full and remain only in abstract form (predominantly in Proceedings of 39th and 40th ASMS Conferences on Mass Spectrometry). With time there is no doubt that the full papers derived from these initial reports will eventually appear. Perhaps another major factor slowing publication is that many studies have been carried out with proprietary compounds and it will take several years for patent clearance to be obtained for the full release of all the findings to take place. The pharmaceutical industry has certainly been at the forefront of implementing API–based methodology and this perhaps reflects the utility of these techniques for studies on drug disposition. Several reviews have appeared recently on the use of MS in drug disposition (Baillie 1992; Garland and Vandenheuvel 1992), pharmacology (Abramson 1990; Fenselau 1992), and biology (Burlingame and McCloskey 1990; Suelter and Watson 1990; McEwen and Larsen 1990; McCloskey 1991; Gross 1992; Stroh and Rinehart 1992).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abdel-Baky S, Giese RW (1991) Gas chromatography/electron capture negative–ion mass spectrometry at the zeptomole level. Anal Chem 63: 2986–2989
Abramson FP (1990) Mass spectrometry in pharmacology. Methods Biochem Anal 34: 289–347
Ackermann R, Kaiser G, Schueller F, Dieterle W (1991) Determination of the antidepressant levoprotiline and its N-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry. Biol Mass Spectrom 20: 709–716
Agostini O, Moneti G, Bonacchi G, Fedi M, Manzini S (1989) Determination of the antihypertensive drug l-[2-ethoxy-2-(3’-pyridyl)ethyl]-4-(2’-methoxyphenyl) piperazine (IP/66) in rat and human plasma by high–performance liquid chromatography and isotope dilution mass spectrometry. J Chromatogr 487: 331–340
Akman SA, Doroshow JH, Burk TG, Dizdaroglu M (1992) DNA base modifications induced in human chromatin by NADH dehydrogenase-catalyzed reduction of doxorubicin. Biochemistry 31: 3500–3506
Ali MH, Abramson FP, Ferrerolf DD, Cohn VH (1990a) Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: distribution of parent drug and ten metabolites obtained from control and schistosomeinfected mouse urine. Biomed Environ Mass Spectrom 19: 186–190
Ali MH, Ferrerolf DD, Abramson FP, Cohn VH (1990b) Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: qualitative identification of 17 hydroxylated metabolites from mouse urine. Biomed Environ Mass Spectrom 19: 179–185
Amark P, Beck O (1992) Effect of phenylpropanolamine on incontinence in children with neurogenic bladders. A double-blind crossover study. Acta Paediatr 81: 345–350
Anderegg RJ (1990) Mass spectrometry: an introduction. Methods Biochem Anal 34: 1–89
Andrievsky GV, Sukhodub LF, Pyatigorskaya L, Boryak A, Limanskaya OY, Shelkovsky VS (1991) Direct observation of the alkylation products of deoxyguanosine and DNA by fast atom bombardment mass spectrometry. Biol Mass Spectrom 20: 665–668
Aoyama T, Kotaki H, Honda Y, Nakagawa F (1990) Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method. J Pharm Sci 79: 465–469
Aronoff G, Brier M, Mayer ML, Barbalas M, Aogaichi K, Sloan R, Brazzell R, Massarella J (1991) Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function. J Clin Pharmacol 31: 38–44
Arpino P (1990) Combined liquid-chromatography mass spectrometry. Techniques and mechanisms of thermospray. Mass Spectrom Rev 9: 631–669
Atsumi R, Suzuki W, Hakusui H (1991) Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion. Xenobiotica 9: 1159–1169
Avery MJ, Mitchell DY, Falkner FC, Fouda HG (1992) Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Biol Mass Spectrom 21: 353–357
Baillie TA (1992) Advances in the application of mass spectrometry to studies of drug metabolism, pharmacokinetics and toxicology. Int J Mass Spectrom Ion Processes 118: 289–314
Baillie TA, Jones JR (eds) (1989) Synthesis and applications of isotopically labeled compounds 1988. Elsevier, Amsterdam
Baillie TA, Adams WJ, Kaiser DG, Olanoff LS, Halsted GW, Harpootlian H, Van Giessen GJ (1989) Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J Pharmacol Exp Ther 249: 517–523
Barbalas MP, Garland WA (1991) A computer program for the deconvolution of mass spectral peak abundance data from experiments using stable isotopes. J Pharm Sci 80: 922–927
Bastholt L, Johansson C-J, Pfeiffer P, Svensson L, Johansson S-A, Gunnarsson PO, Mouridsen H (1991) A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients. Cancer Chem Pharmacol 28: 205–210
Baumann P, Jonzier-Perey M (1988) GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin. Clin Chim Acta 171: 211–222
Beattie IG, Blake TJA (1978) The structural identification of drug metabolites using thermospray liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom 18: 872–877
Benfenati E, Farina P, Colombo T, DeBellis G, Capodiferro MV, D’lncalci M (1989) Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno)benzoic acid in M5076 sarcoma-bearing mice. Cancer Chemother Pharmacol 24: 354–358
Beresford AP, Macrae PV, Alker D, Kobylecki RJ (1989) Biotransformation of amlodipine. Identification and synthesis of metabolites found in rat, dog and human urine/confirmation of structures by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. Arzneimittelforschung 39: 201–209
Berger BJ, Lombardy RJ, Marbury GD, Bell CA, Dykstra CC, Hall JE, Tidwell RR (1990) Metabolic N-hydroxylation of pentamidine in vitro. Antimicrob Agents Chemother 34: 1678–1684
Beynon JH, Morgan RP (1978) The development of mass spectroscopy: an historical account. Int J Mass Spectrom Ion Physics 27: 1–30
Bezek S, Kukan M, Kallay Z, Trnovec T, Stefek M, Piotrovskiy LB (1990) Disposition of ethimizol, a xanthine-related nootropic drug, in perfused rat liver and isolated hepatocytes. Drug Metab Dispos 18: 88–95
Bjorge SM, Baillie TA (1991) Studies on the β-oxidation of valproic acid in rat liver mitochondrial preparations. Drug Metab Dispos 19: 823–829
Blair IA (1990) Electron-capture negative-ion chemical ionization mass spectrometry of lipid mediators. Methods Enzymol 187: 13–23
Blake TJ (1987) Structure elucidation of drug metabolites using thermospray liquid chromatography-mass spectrometry. J Chromatogr 394: 171–181
Blanz J, Mewes K, Ehninger G, Proksch B, Greger B, Waidelich D, Zeller K-P (1991a) Isolation and structure elucidation of urinary metabolites of mitoxantrone. Cancer Res 51: 3427–3433
Blanz J, Mewes K, Ehninger G, Proksch B, Waidelich D, Greger B, Zeller K-P (1991b) Evidence for oxidative activation of mitoxantrone in human, pig, and rat. Drug Metab Dispos 19: 871–880
Bowers LD (1989) High–performance liquid chromatography/mass spectrometry: state of the art for the analysis laboratory. Clin Chem 35: 1282–1287
Brashear WT, Kuhnert BR, Wei R (1990) Structural determination of the conjugated metabolites of ritodrine. Drug Metab Dispos 18: 488–493
Brown ND, Phillips LR, Leader H, Chiang PK (1991) Isolation and identification of β-hydroxyethylaprophen: a urinary metabolite of aprophen in rats. J Chromatogr 563: 466–471
Brown SY, Garland WA, Fukuda EK (1990a) Gas chromatography/negative chemical ionization mass spectrometry of intact glucuronides. Biomed Environ Mass Spectrom 19: 32–36
Brown SY, Garland WA, Fukuda EK (1990b) Isolation and characterization of an unusual glucuronide conjugate of ramantadine. Drug Metab Dispos 18: 546–547
Browne TR (1990) Stable isotopes in clinical pharmacokinetic investigations. Advantages and disadvantages. Clin Pharmacokinet 18: 423–433
Browne TR, Szabo GK, Schumacher GE, Greenblatt DJ, Evans JE, Evans BA (1992) Bioavailability studies of drugs with nonlinear pharmacokinetics. I. Tracer dose AUC varies directly with serum concentration. J Clin Pharmacol 32: 1141–1145
Bruins AP (1991) Mass spectrometry with ion sources operating at atmosphericpressure. Mass Spectrom Rev 10: 53–77
Bryce TA, Chamberlain J, Hillbeck D, Macdonald CM (1989) Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers. Arzneimittelforschung 39: 512–517
Burinsky DJ, Dunphy R, Oyler AR, Shaw CJ, Cotter ML (1992) Characterization of a synthetic peptide impurity by fast-atom bombardment-tandem mass spectrometry and gas chromatography-mass spectrometry. J Pharm Sci 81: 597–600
Burlingame AL, McCloskey JA (eds) (1990) Biological mass spectrometry. Elsevier, Amsterdam
Burlingame AL, Millington DS, Norwood DL, Russell DH (1990) Mass spectrometry. Anal Chem 62: 268R–303R
Burlingame AL, Baillie TA, Russell DH (1992) Mass spectrometry. Anal Chem 64: 467R–502R
Caprioli RM (1990a) Continuous-flow fast atom bombardment mass spectrometry. Anal Chem 62: 477A–485A
Caprioli RM (ed) (1990b) Continuous-flow fast atom bombardment mass spectrometry. Wiley, New York
Caprioli RM, Lin S-N (1990) On-line analysis of penicillin blood levels in the live rat by combined microdialysis/fast-atom bombardment mass spectrometry. Proc Natl Acad Sci USA 87: 240–243
Carr SA, Hemling ME, Bean MF, Roberts GD (1991) Integration of mass spectrometry in analytical biotechnology. Anal Chem 63: 2802–2824
Celardo A, Dell’Elba G, Frassanito R (1991) Simultaneous determination of isbufylline and its major metabolites in rabbit blood and urine by reversed-phase highperformance liquid chromatography. J Chromatogr 568: 407–418
Chace DH, Abramson FP (1990) Isotope dilution studies: determination of carbon-13, nitrogen-15 and deuterium-enriched compounds using capillary gas Chromatography-chemical reaction interface/mass spectrometry. Biomed Environ Mass Spectrom 19: 117–122
Chait BT, Kent SBH (1992) Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins. Science 257: 1885–1894
Chan RL, Hsieh SC, Haroldsen PE, Ho W, Nestor JJ Jr (1991) Disposition of RS-26306, a potent luteinizing hormone-releasing hormone antagonist, in monkeys and rats after single intravenous and subcutaneous administration. Drug Metab Dispos 19: 858–864
Chang SY, Moore TA, Devaud LL, Taylor CE, Hollingsworth EB (1991) Analysis of rat brain microdialysate by gas chromatography-high-resolution selected-ion monitoring mass spectrometry. J Chromatogr 562: 111–118
Changchit A, Gal J, Zirrolli JA (1991) Stereospeciflc gas chromatographic/mass spectrometric assay of the chiral labetalol metabolite 3-amino-1-phenylbutane. Biol Mass Spectrom 20: 751–758
Chanoine F, Grenot C, Sellier N, Barrett WE, Thompson RM, Fentiman AF, Nixon JR, Goyer R, Junien JL (1987) Isolation and identification of major metabolites to tixocortol pivalate in human urine. Drug Metab Dispos 15: 868–876
Chen T-M, Chan KY, Coutant JE, Okerholm RA (1991) Determination of the metabolites of terfenadine in human urine by thermospray liquid chromatography-mass spectrometry. J Pharm Biomed Anal 9: 929–933
Chi HT, Ramu K, Baker JK, Hufford CD, Lee I-S (1991) Identification of the in vivo metabolites of the antimalarial arteether by thermospray high-performance liquid chromatography/mass spectrometry. Biol Mass Spectrom 20: 609–628
Christians U, Radeke H, Kownatzki R, Schiebel HM, Schottmann R, Sewing K-F (1991a) Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations. Clin Biochem 24: 271–275
Christians U, Strohmeyer S, Kownatzki R, Schiebel H-M, Bleck J, Greipel J, Kohlhaw K, Schottmann R, Sewing K-F (1991b) Investigations on the metabolic pathways of cyclosporine. I. Excretion of cyclosporine and its metabolites in human bile-isolation of 12 new cyclosporine metabolites. Xenobiotica 21: 1185–1198
Christians U, Strohmeyer S, Kownatzki R, Schiebel H-M, Bleck J, Kohlhaw K, Schottmann R, Sewing K-F (1991c) Investigations on the metabolic pathways of cyclosporine. II. Elucidation of the metabolic pathways in vitro by human liver microsomes. Xenobiotica 21: 1199–1210
Cocchiara G, Benedetti MS, Vicario GP, Ballabio M, Gioia B, Vioglio S, Vigevani A (1989) Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers. Xenobiotica 19: 769–780
Cottrell JS, Evans S (1987) Characteristics of a multichannel electrooptical detection system and its application to the analysis of large molecules by fast atom bombardment mass spectrometry. Anal Chem 59: 1990–1995
Coutant JE, Barbuch RJ, Satonin DK, Cregge RJ (1987) Identification in man of urinary metabolites of a new bronchodilator, MDL 257, using triple stage quadrupole mass spectrometry-mass spectrometry. Biomed Environ Mass Spectrom 14: 325–330
Coutts RT, Hussain MS, Micetich RG, Daneshtalab M (1990) The metabolism of trimipramine in the rat. Biomed Environ Mass Spectrom 19: 793–806
Coutts RT, Jamali F, Malek F, Peliowski A, Finer NN (1991) Urinary metabolites of doxapram in premature neonates. Xenobiotica 21: 1407–1418
Cretton EM, Waterhous DV, Bevan R, Sommadossi J-P (1990) Glucuronidaation of 3’-azido-3’-deoxythymidine by rat and human liver microsomes. Drug Metab Dispos 18: 369–372
Cretton EM, Xie M-Y, Bevan RJ, Goudgaon NM, Schinazi RF, Sommadossi J-P (1991) Catabolism of 3’-azido-3’-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3’-amino-3’-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Mol Pharmacol 39: 258–266
Cushnir JR, Naylor S, Lamb JH, Farmer PB, Brown NA, Mirkes PE (1990) Identification of phosphoramide mustard/DNA adducts using tandem spectrometry. Rapid Commun Mass Spectrom 4: 410–414
Daumas L, Sabot J-F, Vermeulen E, Clapot P, Allegre F, Pinatel H (1991) Determination of debrisoquine and metabolites in human urine by gas chromatographymass spectrometry. J Chromatogr 570: 89–97
Dawson M, Smith MD, McGee CM (1990) Gas chromatography/negative ion chemical ionization/tandem mass spectrometric quantification of indomethacin in plasma and synovial fluid. Biomed Environ Mass Spectrom 19: 453–458
Debrauwer L, Bories G (1992) Electrospray ionization mass spectrometry of some β-agonists. Rapid Commun Mass Spectrom 6: 382–387
Desage M, Rousseau–Tsangaris M, Lecompte D, Brazier JL (1991) Quantification of trihexyphenidyl from plasma using a mass-selective detector and electron-impact ionization. J Chromatogr 571: 250–256
De Vries JX, Walter-Sack I, Ittensohn A, Weber E (1989) The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man. Xenobiotica 19: 1461–1470
Dobson RLM, Neal DM, DeMark BR, Ward SR (1990) Long-term performance of a gas chromatography/tandem mass spectrometry assay for tebufelone in plasma. Anal Chem 62: 1819–1824
Doig MV, Clare RA (1991) Use of the thermospray liquid chromatography-mass spectrometry to aid in the identification of urinary metabolites of a novel antiepileptic drug, Lamotrigine. J Chromatogr 554: 181–189
Dole M, Mack LL, Hines RL (1968) Molecular beams of macroions. J Chem Phys 49: 2240–2249
Dulik DM, Fenselau C (1987) Conversion of melphalan to 4-(glutathionyl)phenylalanine. A novel mechanism for conjugation by glutathione-S-transferases. Drug Metab Dispos 15: 195–199
Dulik DM, Colvin OM, Fenselau C (1990) Characterization of glutathione conjugates of chlorambucil by fast atom bombardment and thermospray liquid chromatography /mass spectrometry. Biomed Environ Mass Spectrom 19: 248–252
Eckhoff C, Wittfoht W, Nau H, Slikker W Jr (1990) Characterization of oxidized and glucuronidated metabolites of retinol in monkey plasma by thermospray liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom 19: 428–433
Eichhold TH, Doyle MJ (1990) Determination of tebufelone, a new anti-inflammatory drug, in plasma and tissue using capillary gas chromatography-stable isotope dilution mass spectrometry. Biomed Environ Mass Spectrom 19: 230–234
Eriksson UG, Hoffmann K-J, Simonsson R, Regardh CG (1991) Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture. Xenobiotica 21: 75–84
Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH (1991) Biotransformation of pravastatin sodium in humans. Drug Metab Dispos 19: 740–748
Felder TB, McLean MA, Vestal ML, Lu K, Farquhar D, Legha SS, Shah R, Newman RA (1987) Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans. Drug Metab Dispos 15: 773–778
Fenn JB, Mann M, Meng CK, Wong SF, Whitehou CM (1990) Electrospray ionization — principles and practice. Mass Spectrom Rev 9: 37–70
Fenselau C (1992) Tandem mass spectrometry: the competitive edge for pharmacology. Annu Rev Pharmacol Toxicol 32: 555–578
Fischer C, Schonberger F, Meese CO, Eichelbaum M (1990) Determination of the enantiomers of flecainide and two major metabolites in man by gas chromatography/mass spectrometry using negative ion chemical ionization and stable isotope labelled internal standards. Biomed Environ Mass Spectrom 19: 256–266
Fisher AL, Morris MJ, Gilbert JD (1991) Determination of MK-287, a new plateletactivating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry. Biol Mass Spectrom 20: 408–414
Fisher E, Wittfoht W, Nau H (1992) Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry. Biomed Chromatogr 6: 24–29
Fouda HG, Lukaszewicz J, Clark DA, Hulin B (1991a) Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry. Xenobiotica 21: 925–934
Fouda HG, Nocerini M, Schneider R, Gedutis C (1991b) Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: the determination of the renin inhibitor CP-80,794 in human serum. J Am Soc Mass Spectrom 2: 164–167
Fujimaki Y, Hashimoto K, Sudo K, Tachizawa H (1990) Biotransformation of a new pyrrolidinone cognition-enhancing agent: isolation and identification of metabolites in human urine. Xenobiotica 20: 1081–1094
Funke PT, Ivashkiv E, Arnold ME, Cohen AI (1989) Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gaschromatography/negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 18: 904–909
Gal J, Zirrolli JA, Lichtenstein PS (1988) Labetalol is metabolized oxidatively in humans. Res Commun Chem Pathol Pharmacol 62: 3–17
Garland WA, VandenHeuvel V (eds) (1992) Mass spectrometry in pharmaceutical research: current boundaries and future frontiers. Wiley, New York
Gaudry D, Hayes M, Khemani L, Miotto J, Alkalay D (1991) Determination of CGS 16617 and stable isotope-labeled CGS 16617, an angiotensin-converting enzyme inhibitor, in human plasma by gas chromatography/mass spectrometry. Biol Mass Spectrom 20: 26–30
Ghabrial H, Prakash C, Tacke UG, Blair IA, Wilkinson GR (1991) Geometric isomerization of doxepin during its N-demethylation in humans. Drug Metab Dispos 19: 596–599
Gilbert JD, Hand EL, Yuan AS, Olah TV, Covey TR (1992) Determination of L-365,260, a new cholecystokinin receptor (CCK-B) antagonist, in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Biol Mass Spectrom 21: 63–68
Girault J, Fourtillan JB (1988) Quantitative measurement of clonidine in human plasma by combined gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 17: 443–448
Girault J, Gobin P, Fourtillan JB (1990a) Quantitative measurement of clenbuterol at the femtomole level in plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 19: 80–88
Girault J, Istin B, Fourtillan JB (1990b) A rapid and highly sensitive method for the quantitative determination of dexamethasone in plasma, synovial fluid and tissues by combined gas chromatography /negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 19: 295–302
Good SS, Koble CS, Crouch R, Johnson RL, Rideout JL, Miranda PD (1990) Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans. Drug Metab Dispos 18: 321–326
Gouyette A, Deniel A, Pico JL, Droz JP, Baume D, Ostronoff M, Bail N-L, Hayat M (1987) Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies. Eur J Cancer Clin Oncol 23: 1627–1632
Grech-Belanger O, Turgeon J, Lalande M, Belanger PM (1991) Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation. Drug Metab Dispos 19: 458–461
Gross ML (ed) (1992) Mass spectrometry in the biological sciences: a tutorial. Kluwer, Dordrecht
Guilluy R, Billion-Rey F, Brazier JL (1991) On-line measurements of 13C enrichments in rat breath. Non-invasive method for in vivo study of drug enzymatic induction. J Chromatogr 562: 341–350
Haim N, Nemec J, Roman J, Sinha BK (1987) In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. Biochem Pharmacol 36: 527–536
Hamdan M, Curcuruto O (1991) Development of the electrospray ionisation technique. Int J Mass Spectrom Ion Processes 108: 93–113
Hande K, Anthony L, Hamilton R, Bennett R, Sweetman B, Branch R (1988) Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit. Cancer Res 48: 1829–1834
Haring N, Salama Z, Reif G, Jaeger H (1988) Gas chromatography/mass spectrometric determination of clonidine in body fluids. Arzneimittelforschung 38: 404–407
Haroldsen PE, Reilly MH, Hughes H, Gaskell SJ (1988) Characterization of glutathione conjugates by fast atom bombardment/tandem mass spectrometry. Biomed Environ Mass Spectrom 15: 615–621
Hartman NR, Jardine I (1987) The in vitro activity, radioimmunoassay crossreactivity, and molecular weight of thirteen rabbit cyclosporine metabolites. Drug Metab Dispos 15: 661–664
Haumont M, Magdalou J, Lafaurie C, Ziegler J-M, Siest G, Colin J-N (1990) Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3’-azido-3’-deoxythymidine: characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys 281: 264–270
Heeremans CEM, Stijnen AM, VanDerHoeven RAM, Niessen WMA, Danhof M, VanDerGreef J (1991) Liquid chromatography-thermospray tandem mass spectrometry for identification of a heptabarbital metabolite and sample work-up artefacts. J Chromatogr 554: 205–214
Hill JA, Biller JE, Biemann K (1991) A variable dispersion array detector for a tandem mass spectrometer. Int J Mass Spectrom Ion Processes 111: 1–25
Hillenkamp F, Karas M, Beavis RC, Chait BT (1991) Matrix-assisted laser desorption/ ionization mass spectrometry of biopolymers. Anal Chem 63: 1193A–1202A
Hoffman HE, Gaylord JC, Blasecki JW, Shalaby LM, Whitney CC Jr (1988) Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs. Antimicrob Agents Chemother 32: 1699–1704
Hoffmann K-J, Baillie TA (1988) The use of alkoxycarbonyl derivatives for the mass spectral analysis of drug-thioether metabolites. Studies with the cysteine, mercapturic acid and glutathione conjugates of acetaminophen. Biomed Environ Mass Spectrom 15: 637–647
Hofmann U, Eichelbaum M, Seefried S, Meese CO (1991) Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine. Drug Metab Dispos 19: 222–226
Hogemann A, Kiec-Kononowicz K, Westhoff F, Blashke G (1990) Microsomal oxidation of praziquantel. Arzneimittelforschung 40: 1159–1162
Huang EC, Henion JD (1991) Packed-capillary liquid chromatography/ion-spray tandem mass spectrometry determination of biomolecules. Anal Chem 63: 732–739
Huang EC, Wachs T, Conboy JJ, Henion JD (1990) Atmospheric pressure ionization mass spectrometry. Detection for the separation sciences. Anal Chem 62: 713A–725A
Iwabuchi H, Nakagawa A, Nakamura K-I (1987) Application of molecular-secondaryion mass spectrometry for drug metabolism studies. I. Direct analysis of conjugates by thin-layer chromatography-secondary-ion mass spectrometry. J Chromatogr 414: 139–148
Jackson C-JC, Hubbard JW, Midha KK (1991a) Biosynthesis and characterization for glucuronide metabolites of fluphenazine: 7-hydroxyfluphenazine glucuronide and fluphenazine glucuronide. Xenobiotica 21: 383–393
Jackson C-JC, Hubbard JW, McKay G, Cooper JK, Hawes EM, Midha KK (1991b) Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Drug Metab Dispos 19: 188–193
Jacobs PL, Delbressine LPC, Kaspersen FM, Schmeits GJH (1987) A mass spectrometric approach to the identification of conjugated drug metabolites. Biomed Environ Mass Spectrom 14: 689–697
Jajoo HK, Mayol RF, LaBudde JA, Blair IA (1989a) Metabolism of the antianxiety drug buspirone in the rat. Drug Metab Dispos 17: 625–633
Jajoo HK, Mayol RF, LaBudde JA, Blair IA (1989b) Metabolism of the antianxiety drug buspirone in human subjects. Drug Metab Dispos 17: 634–640
Jajoo HK, Blair IA, Klunk LJ, Mayol RF (1990a) Characterization of in vitro metabolites of the antipsychotic drug tiospirone by mass spectrometry. Biomed Environ Mass Spectrom 19: 281–285
Jajoo HK, Blair IA, Klunk LJ, Mayol RF (1990b) In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo. Xenobiotica 20: 779–786
Jajoo HK, Mayol RF, LaBudde JA, Blair IA (1990c) Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects. Drug Metab Dispos 18: 28–35
Jaworski TJ, Hawes EM, Hubbard JW, McKay G, Midha KK (1991) The metabolites of chlorpromazine N-oxide in rat bile. Xenobiotica 21: 1451–1459
Jemal M, Ivashkiv E, Both D, Koski R, Cohen Al (1987) Picogram level determination of fluphenazine in human plasma by automated gas chromatography/mass selective detection. Biomed Environ Mass Spectrom 14: 699–704
Jindal SP, Lutz T (1989) Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labeled analogues. J Pharm Sci 78: 1009–1014
Johansson IM, Pavelka R, Henion JD (1991) Determination of small drug molecules by capillary electrophoresis-atmospheric pressure ionization mass spectrometry. J Chromatogr 559: 515–528
Jonkman JHG, Borgstrom L, VanDerBoon WJV, DeNoord OE (1988) Theophyllineterbutaline, a steady state study on possible pharmacokinetic interactions with special reference to chronopharmacokinetic aspects. Br J Clin Pharmacol 26: 285–293
Kajbaf M, Lamb JH, Naylor S, Pattichis K, Gorrod JW (1991) Identification of metabolites derived from the H2-receptor antagonist mifentidine using tandem mass spectrometry. Anal Chim Acta 247: 151–159
Kajbaf M, Jahanshahi M, Pattichis K, Gorrod JW, Naylor S (1992) Rapid and efficient purification of cimetropium bromide and mifentidine drug metabolite mixtures derived from microsomal incubates for analysis by mass spectrometry. J Chromatogr 575: 75–85
Kamimura H, Enjoji Y, Sasaki H, Kawai R, Kaniwa H, Niigata K, Kageyama S (1987) Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats. Xenobiotica 17: 645–658
Kaspersen FM, Van Boeckel CAA (1987) A review of the methods of chemical synthesis of sulphate and glucuronide conjugates. Xenobiotica 17: 1451–1471
Kassahun K, Burton R, Abbott FS (1989) Negative ion chemical ionization gas chromatography/mass spectrometry of valproic acid metabolites. Biomed Environ Mass Spectrom 18: 918–926
Kassahun K, Farrell K, Zheng J, Abbott F (1990) Metabolic profiling of valproic acid in patients using negative-ion chemical ionization gas chromatography-mass spectrometry. J Chromatogr 527: 327–341
Kassahun K, Farrell K, Abbott F (1991) Identification of characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab Dispos 19: 525–535
Kasuya F, Igarashi K, Fukui M (1991) Metabolism of chlorpheniramine in rat and human by use of stable isotopes. Xenobiotica 21: 97–109
Kayganich K, Watson JT, Kilts C, Ritchie J (1990) Determination of plasma dexamethasone by chemical oxidation and electron capture negative ionization mass spectrometry. Biomed Environ Mass Spectrom 19: 341–347
Kelly DW, Holder CL, Korfmacher WA, Slikker W Jr (1990) Plasma elimination and urinary excretion of methapyrilene in the rat. Drug Metab Dispos 18: 1018–1024
Kenny PTM, Orlando R (1992) Tandem mass spectrometric analysis of peptides at the femtomole level. Anal Chem 64: 957–960
Keswani SR, Edfort MJ, Wilhelm JA, Kvalo LT, Venturella VS (1990) Sensitive method for the determination of pentamorphone is serum by liquid chromatography-mass spectrometry with thermospray interface. J Chromatogr 534: 77–86
Kharasch ED, Hill HF, Eddy AC (1991) Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism. Anesthesiology 75: 520–524
Kishida K, Akaki Y, Sasabe T, Yamamoto C, Manabe R (1990) Glutathione conjugation of methazolamide and subsequent reactions in the ciliary body in vitro. J Pharm Sci 79: 638–642
Knadler MP, Ackermann BL, Coutant JE, Hurst GH (1992) Metabolism of the anticoagulant peptide, MDL 28,050, in rats. Drug Metab Dispos 20: 89–95
Knapp DR (1979) Handbook of analytical derivatization reactions. Wiley, New York
Kobayashi T, Hohnoki H, Esumi Y, Ohtsuki T, Washino T, Tanayama S (1988) Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate ( MOTP) in rats and dogs. Xenobiotica 18: 49–59
Kokkonen PS, Niessen WMA, Tjaden UR, VanDerGreef J (1991) Bioanalysis of erythromycin 2’-ethylsuccinate in plasma using phase-system switching continuous flow fast atom bombardment liquid chromatography-mass spectrometry. J Chromatogr 565: 265–275
Komatsu S, Murata S, Aoyama H, Zenki T, Ozawa N, Tateishi M, Vrbanac JJ (1991) Microquantitative determination of ciprostene in plasma by gas chromatography-mass spectrometry coupled with an antibody extraction. J Chromatogr 568: 460–466
Korfmacher WA, Freeman JP, Getek TA, Bloom J, Holder CL (1990) Analysis of rat urine for metabolites of pyrilamine via high-performance liquid chromatography/thermospray mass spectrometry and tandem mass spectrometry. Biomed Environ Mass Spectrom 19: 191–201
Korzekwa K, Howard WN, Trager WF (1990) The use of Brauman’s least squares approach for the quantification of deuterated chlorophenols. Biomed Environ Mass Spectrom 19: 211–217
Kosevich MV, Zhilkova OIU (1988) Use of the method of fast atom bombardment mass spectrometry for identification of products of the interaction of thiophosphamide with DNA. Bioorg Khim 14: 1698–1699
Kraft JC, Slikker W Jr, Bailey JR, Roberts LG, Fischer B, Wittfoht W, Nau H (1991) Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-β- glucuronides. A comparison to one human case study with isotretinoin. Drug Metab Dispos 19: 317–324
Kurono M, Itogawa A, Yoshida K, Naruto S, Rudewicz P, Kanai M (1992) Identification of AJ-2615 and its S-oxidized metabolites in rat plasma by use of tandemmass spectrometry. Biol Mass Spectrom 21: 17–21
Kwok DWK, Pillai G, Vaughan R, Axelson JE, McErlane KM (1990) Preparative high-performance liquid chromatography and preparative thin-layer chromatography isolation of tocainide carbamoyl-O-β-D-glucuronide: structural characterization by gas chromatography-mass spectrometry and fast atom bombardment-mass spectrometry. J Pharm Sci 79: 857–861
Lauriault VVM, O’Brien PJ (1991) Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol. Mol Pharmacol 40: 125–134
Lauriault VVM, McGirr LG, Wong WWC, O’Brien PJ (1990) Modulation of benzoquinone-induced cytotoxicity by diethyldithiocarbamate in isolated hepatocytes. Arch Biochem Biophys 282: 26–33
Lauwers W, LeJeune L (1988) Identification of a biliary metabolite of cisapride. Biomed Environ Mass Spectrom 15: 323–328
Lee MS, Yost RA (1988) Rapid identification of drug metabolites with tandem mass spectrometry. Biomed Environ Mass Spectrom 15: 193–204
Lee PW-N, Byerley LO, Bergner EA (1991) Mass isotopomer analysis: theoretical and practical considerations. Biol Mass Spectrom 20: 451–458
Leis HJ, Malle E (1991) Deuterium-labelling and quantitative measurement of ketotifen in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 20: 467–470
Leis HJ, Gleispach H, Nitsche V, Malle E (1990) Quantitative determination of terbutaline and orciprenaline in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry. Biomed Environ Mass Spectrom 19: 382–386
Leloux MS, Maes RAA (1990) The use of electron impact and positive chemical ionization mass spectrometry in the screening of beta blockers and their metabolites in human urine. Biomed Environ Mass Spectrom 19: 137–142
Leloux MS, Maes RAA (1991) Identification and determination of propafenone and its principal metabolites in human urine using capillary gas chromatography/mass spectrometry. Biol Mass Spectrom 20: 382–388
Leung LY, Baillie TA (1989) Studies on the biotransformation of ketamine. II. Quantitative significance of the N-demethylation pathway in rats in vivo determined by a novel stable isotope technique. Biomed Environ Mass Spectrom 18: 401–404
Levy RH, Rettenmeier AW, Anderson GD, Wilensky AJ, Friel PN, Baillie TA, Acheampong A, Tor J, Guyot M, Loiseau P (1990) Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-enevalproate, a hepatotoxic metabolite of valproic acid. Clin Pharmacol Ther 48: 225–235
Li J, Norwood DL, Mao L-F, Schulz H (1991) Mitochondrial metabolism of valproic acid. Biochemistry 30: 388–394
Liu H, Cooper LM, Raynie DE, Pinkston JD, Wehmeyer KR (1992) Combined supercritical fluid extraction/solid-phase extraction with octadecylsilane cartridges as a sample preparation technique for the ultratrace analysis of a drug metabolite in plasma. Anal Chem 64: 802–806
Lonning PE, Lien EA, Lundgren S, Kvinnsland S (1992) Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet 22: 327–358
Loscher W, Nau H, Siemes H (1988) Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy. Epilepsia 29: 311–316
Lunte CE, Scott DO (1991) Sampling living systems using microdialysis probes. Anal Chem 63: 773A–778A
Luo H, Hawes EM, McKay G, Korchinski ED, Midha KK (1991) The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin. Drug Metab Dispos 19: 722–724
MacDonald JI, Dickinson RG, Reid RS, Edom RW, King AR, Verbeeck RK (1991) Identification of a hydroxy metabolite of diflunisal in rat and human urine. Xenobiotica 21: 1521–1533
Macrae PV, Kinns M, Pullen FS, Tarbit MH (1990) Characterization of a quaternary, N-glucuronide metabolite of the imidazole antifungal, tioconazole. Drug Metab Dispos 18: 1100–1102
Madden S, Back DJ (1991) Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitro. J Steroid Biochem Mol Biol 38: 497–503
Madden S, Back DJ, Martin CA, Orme MLE (1989) Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa. Br J Clin Pharmacol 27: 295–299
Magdalou J, Herber R, Bidfault R, Siest G (1992) In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther 260: 1166–1173
Mao L-F, Millington DS, Schulz H (1992) Formation of a free acyl adenylate during the activation of 2-propylpentanoic acid. J Biol Chem 267: 3143–3146
Martin LB III, Schreiner AF, VanBreemen RB (1991) Characterization of cisplatin adducts of oligonucleotides by fast atom bombardment mass spectrometry. Anal Biochem 193: 6–15
Maurer H, Wollenberg P (1990) Urinary metabolites of benzbromarone in man. Arzneimittelforschung 40: 460–462
Maurizis JC, Nicolas C, Verny M, Oilier M, Faurie M, Payard M, Veyre A (1991) Biodistribution and metabolism in rats and mice of bucromarone. Drug Metab Dispos 19: 94–99
May DG, Black CM, Olsen NJ, Cuska ME, Tanner SB, Bellino L, Porter JA, Wilkinson GR, Branch RA (1990) Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin. Clin Pharmacol Ther 48: 286–295
Mayol RF, Jajoo HK, Klunk LJ, Blair IA (1991) Metabolism of the antipsychotic drug tiospirone in humans. Drug Metab Dispos 19: 394–399
Mays DC, Dixon KF, Balboa A, Pawluk LJ, Bauer MR, Nawoot S, Gerber N (1991) A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. J Pharmacol Exp Ther 259: 1261–1270
McCloskey JA (ed) (1991) Methods in enzymology, vol 193. Academic, New York
McEwan CN, Larsen BS (ed) (1990) Mass spectrometry of biological materials, vol 8. Dekker, New York
Meier GP, Park SB, Yee GC, Gmur DJ (1990) Isolation and identification of a novel human metabolite of cyclosporin A: dihydro-CsA M17. Drug Metab Dispos 18: 68–71
Menacherry SD, Justice JB Jr (1990) In vivo microdialysis and thermospray tandem mass spectrometry of the dopamine uptake blocker 1-(2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl)-piperazine (GBR-12909). Anal Chem 62: 597–601
Meuldermans W, Peer AV, Hendrickx J, Woestenborghs R, Lauwers W, Heykants J, Bussche GV, Craeyvelt HV, Der-Aa PV (1988) Alfentanil pharmacokinetics and metabolism in humans. Anesthesiology 69: 527–534
Midha KK, Hawes EM, Hubbard JW, Korchinski ED, McKay G (1989) Intersubject variation in the pharmacokinetics of chlorpromazine in healthy men. J Clin Psychopharmacol 9: 4–8
Mikus G, Eichelbaum M, Fischer C, Gumulka S, Klotz U, Kroemer HK (1990) Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. J Pharmacol Exp Ther 253: 1042–1048
Moini M, Abramson FP (1991) A moving belt device to couple high-performance liquid chromatography and chemical reaction interface mass spectrometry. Biol Mass Spectrom 20: 308–312
Moini M, Chace D, Abramson FP (1990) Selective detection of sulfur-containing compounds by gas chromatography/chemical reaction interface mass spectrometry. J Am Soc Mass Spectrom 2: 250–255
Monsarrat B, Mariel E, Cros S, Gares M, Guenard D, Gueritte-Voegelein F, Wright M (1990) Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos 18: 895–901
Muck WM, Henion JD (1990) High-performance liquid chromatography/tandem mass spectrometry: its use for the identification of stanozolol and its major metabolites in human and equine urine. Biomed Environ Mass Spectrom 19: 37–51
Muindi JRF, Lee S-J, Baltzer L, Jakubowski A, Scher HI, Sprancmanis LA, Riley CM, Velde DV, Young CW (1991) Clinical pharmacology of deoxyspergualin in patients with advanced cancer. Cancer Res 51: 3096–3101
Muindi JRF, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrel RP Jr (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52: 2138–2142
Murray S, Davies DS, Blair IA (1983) Analytical techniques in clinical pharmacology. In: Turner P, Shand DG (ed) Recent advances in clinical pharmacology. Churchill Livingstone, Edinburgh, pp 1–19
Murthy SS, Nelson WL, Shen DD, Power JM, Cahill CM, McLean AJ (1991) Pharmacokinetic interaction between verapamil and metoprolol in the dog: stereochemical aspects. Drug Metab Dispos 19: 1093–1100
Mutlib AE, Nelson WL (1990a) Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes. Drug Metab Dispos 18: 331–337
Mutlib AE, Nelson WL (1990b) Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil. J Pharmacol Exp Ther 252: 593–599
Nakagawa Y, Iwatani K (1991) Scanning thin-layer chromatography-liquid secondary ion mass spectrometry and its application for investigation of drug metabolites. J Chromatogr 562: 99–110
Naylor S, Kajbaf M, Lamb JH, Jahanshahi M, Gorrod JW (1992) Rapid identification of cimetropium bromide metabolites using constant neutral loss tandem mass spectrometry. Biol Mass Spectrom 21: 165–175
Niemeijer NR, Gerding TK, DeZeeuw RA (1991) Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol. Drug Metab Dispos 19: 20–23
Nishioka R, Umeda I, Oi N (1991) Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron–capture detection and their identification by gas chromatography–mass spectrometry. J Chromatogr 565: 237–246
Nordholm L, Wassmann O, Nielsen PG, Thogersen H, Gronvald F (1992) Identification of the major metabolites of [3H]-(+)-8-chloro-5-(2,3-dihydrobenzofuran-7-yl)-7-methoxymethyloxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine in rats. Xenobiotica 22: 345–356
Odar-Cederlof I, Anderson P, Bondesson U (1990) Nifedipine as an antihypertensive drug in patients with renal failure — pharmacokinetics and effects. J Intern Med 227: 329–337
Ottoila P, Pakkala E, Karlsson C, Taskinen J (1991) Determination of nitecapone and (13C6)nitecapone in human plasma by gas chromatography/mass spectrometry. Biol Mass Spectrom 20: 771–776
Paar WD, brockmeier D, Hirzebruch M, Schmidt EK, von Unruh GE, Dengler HJ (1990) Pharmacokinetics of prenylamine racemate and enantiomers in man. Arzneimittelforschung 40: 657–661
Pan HY, Triscari J, DeVault AR, Smith SA, Wang–Iverson D, Swanson BN, Willard DA (1991) Pharmacokinetic interaction between propranolol and the HMGCoA reductase inhibitors pravastatin and lovastatin. Br J Clin Pharmacol 31: 665–670
Patanella JE, Walsh JS, Unger SE, Miwa GT, Parry PS, Daniel MJ, Evans GL (1990) Identification of a glucuronide conjugate of the carbocyclic nucleoside, carbovir, isolated from marmoset urine. Drug Metab Dispos 18: 1092–1095
Patel DK, Woolley JL Jr, Shockcor JP, Johnson RL, Taylor LC, Sigel CW (1991) Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat. Drug Metab Dispos 19: 491–497
Pearson PG, Threadgill MD, Howald WN, Baillie TA (1988) Applications of tandem mass spectrometry to the characterization of derivatized glutathione conjugates. Studies with S-(N-methylcarbamoyl)-glutathione, a metabolite of the antineoplastic agent N-methylformamide. Biomed Environ Mass Spectrom 16: 51–56
Peng GW, Chiou WL (1990) Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies. J Chromatogr 531: 3–50
Perkins JR, Parker CE, Tomer KB (1992) Nanoscale separations combined with electrospray ionization mass spectrometry: sulfonamide determination. J Am Soc Mass Spectrom 3: 139–149
Poon GK, Jarman M, Rowlands MG, Dowsett M, Firth J (1991a) Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry. J Chromatogr 565: 75–88
Poon GK, McCague R, Griggs LJ, Jarman M, Lewis IAS (1991b) Characterization of metabolites of 3-ethyl-3-(4-pyridyl)-piperadine-2,6-dione, potential breast cancer drug. J Chromatogr 572: 143–157
Poon GK, Mistry P, Lewis S (1991c) Electrospray ionization mass spectrometry of platinum anticancer agents. Biol Mass Spectrom 20: 687–692
Porubek DJ, Barnes H, Theodore LJ, Baillie TA (1988) Enantioselective synthesis and preliminary metabolic studies of the optical isomers of 2-n-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproic acid. Chem Res Toxicol 1: 343–348
Prakash C, Adedoyin A, Wilkinson GR, Blair IA (1991) Enantiospecific quantification of hexobarbital and its metabolites in biological fluids by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 20: 559–564
Puppo MD, Cighetti G, Kienle MG, Paroni R, Borghi C (1991) Determination of diclofenac in human plasma by selected ion monitoring. Biol Mass Spectrom 20: 426–430
Rashed MS, Pearson PG, Han D-H, Baillie TA (1989) Application of liquid chromatography/thermospray mass spectrometry to studies on the formation of glutathione and cysteine conjugates from monomethylcarbamate metabolites of bambuterol. Rapid Commun Mass Spectrom 3: 360–363
Rettenmeier AW, Howard WN, Levy RH, Witek DJ, Gordon WP, Porubek DJ, Baillie TA (1989) Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques. Biomed Environ Mass Spectrom 18: 192–199
Robinson PR, Jones MD, Maddock J, Rees LW (1991) Simultaneous determination of clebopride and a major metabolite N-desbenzylclebopride in plasma by capillary gas chroamtography-negative-ion chemical ionization mass spectrometry. J Chromatogr 564: 147–161
Rubio FR, Crews T, Garland WA, Fukuda EK (1988) Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom 17: 399–404
Sanins SM, Adams WJ, Kaiser DG, Halstead GW, Baillie TA (1990) Studies of the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab Dispos 18: 527–533
Sanins SM, Adams WJ, Kaiser DG, Halstead GW, Hosley J, Barnes H, Baillie TA (1991) Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metab Dispos 19: 405–410
Sasaki Y, Baba S (1988) Simultaneous determination for imipramine, despramine and their deuterium-labeled analogues in biological fluids by capillary gas chromatography-mass spectrometry. J Chromatogr 426: 93–101
Scappaticci B, Souveyrand J, Rousseau-Tsangaris M, Desage M, Brazier JL, Coquet B (1990) Determination of sodium diethyldithiocarbamate (imuthiol) and its Smethyl metabolite by gas chromatography-mass spectrometry. J Chromatogr 534: 57–66
Scatina JA, Lockhead SR, Cayen MN, Sisenwine SF (1991) Metabolic disposition of enciprazine, a non-benzodiazepine anxiolytic drug, in rat, dog and man. Xenobiotica 21: 1591–1604
Schellenberg KH, Linder M, Groeppelin A, Erni F (1987) Experience with routine applications of liquid chromatography-mass spectrometry in the pharmaceutical industry. J Chromatogr 394: 239–251
Scherling D, Karl W, Ahr G, Ahr HJ, Wehinger E (1988) Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man. Arzneimittelforschung 38: 1105–1110
Schneider RP, Lynch MJ, Ericson JF, Fouda HG (1991) Electrospray ionization mass spectrometry of semduramicin and other polyether ionophores. Anal Chem 63: 1789–1794
Shaheen O, Biollaz J, Koshakji RP, Wilkinson GR, Wood AJJ (1989) Influence of debrisoquin phenotype on the inducibility of propranolol metabolism. Clin Pharmacol Ther 45: 439–443
Shinohara Y, Baba S (1990) Stable isotope methodology in the pharmacokinetic studies of androgenic steroids in humans. Steroids 55: 170–176
Shinohara Y, Kirii N, Tamaoki H, Magara H, Baba S (1990) Determination of the enantiomers of suprofen and [2H3]suprofen in plasma by capillary gas chromatography- mass spectrometry. J Chromatogr 525: 93–104
Shinohara Y, Magara H, Baba S (1991) Stereoselective pharmacokinetics and inversion of suprofen enantiomers in humans. J Pharm Sci 80: 1075–1078
Shipley LA, Coleman MD, Brewer TG, Ashmore RW, Theoharides AD (1990) The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver; thermospray liquid chromatography-mass spectrometry identification of metabolites. Xenobiotica 20: 31–44
Shu Y-Z, Hubbard JW, Cooper JK, McKay G, Korchinski ED, Kumar R, Midha KK (1990a) The identification of urinary metabolites of doxepin in patients. Drug Metab Dispos 18: 735–741
Shu Y-Z, Hubbard JW, McKay G, Midha KK (1990b) Identification of phenolic doxepin glucuronides from patient urine and rat bile. Drug Metab Dispos 18: 1096–1099
Siegel MM, Hollander IJ, Hamann PR, James JP, Hinman L, Smith BJ, Farnsworth APH, Phipps A, King DJ, Karas M, Ingendoh A, Hillenkamp F (1991) Matrixassisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator, and conjugated drug content. Anal Chem 63: 2470–2481
Sinz MW, Remmel RP (1991) Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine. Drug Metab Dispos 19: 149–153
Slatter JG, Abbott FS, Burton R (1990) Identification of the biliary metabolites of (+)-3-dimethylamino-1,1-diphenylbutane HCI (recipavrin) in rats. Xenobiotica 20: 999–1024
Smith RD, Loo JA, Edmonds CG, Barinaga CJ, Udseth HR (1990) New developments in biochemical mass spectrometry: electrospray ionization. Anal Chem 62: 882–899
Stahl W, Lenhardt S, Przybylski M, Eisenbrand G (1992) Mechanism of glutathionemediated DNA damage by the antineoplastic agent l,3-bis(2-chloroethyl) –N-nitrosourea. Chem Res Toxicol 5: 106–109
Stiff DD, Zemaitis MA (1990) Metabolism of the anticonvulsant agent zonisamide in the rat. Drug Metab Dispos 18: 888–894
Straub KM, Rudewicz P, Garvie C (1987) “Metaboloic mapping” of drugs: rapid screening techniques for xenobiotic metabolites with m.s./m.s. techniques. Xenobiotica 17:413–422
Straub K, Davis M, Hwang B (1988) Benzazepine metabolism revisited. Evidence for the formation of novel amine conjugates. Drug Metab Dispos 16: 359–366
Stroh JG, Rinehart KL (1992) Liquid chromatography/fast atom bombardment mass spectrometry. In: Russell DH (ed) Experimental mass spectrometry. Plenum, New York
Subramanyam B, Pond SM, Eyles DW, Whiteford HA, Fouda HG, Castagnoli N Jr (1991) Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol. Biochem Biophys Res Commun 181: 573–578
Suelter CH, Watson JT (eds) (1990) Biomedical applications of mass spectrometry. Wiley, Chichester
Sweeny DJ, Barnes S, Heggie GD, Diasio RB (1987) Metabolism of 5-fluorouracil to an N-cholyl-2-fluoro-β-alanine conjugate: previously unrecognized role for bile acids in drug conjugation. Proc Natl Acad Sci USA 84: 5439–5443
Takano T, Abe S, Hata S (1990) A selected ion monitoring method for quantifying simvastatin and its acid form in human plasma, using the ferroceneboronate derivate. Biomed Environ Mass Spectrom 19: 577–581
Tanaka M, Ono K, Hakusui H, Takegoshi T, Watanabe Y, Kanao M (1990) Identification of DP-1904 and its ester glucuronide in human urine and determination of their enantiomeric compositions by high-performance liquid chromatography with optical activity and ultraviolet detection. Drug Metab Dispos 18: 698–703
Theodor R, Weimann H-J, Weber W, Michaelis K (1991) Absolute bioavailability of moxonidine. Eur J Drug Metab Pharmacokinet 16: 153–159
Thornburgh BA, Shaw SR, Bronson GE, Sinha AJW (1988) Isolation and characterization of the urinary metabolites of arbaprostil in the male dog after intravenous administration. Eur J Drug Metab Pharmacokinet 13: 113–121
Tracy JW, Catto BA, Webster LT Jr (1991) Formation of N-(5-nitro-2-thiazolyl)-N’-carboxymethylurea from 5-hydroxyniridazole. Role of aldehyde dehydrogenase in the oxidative metabolism of niridazole. Drug Metab Dispos 19: 508–515
Treston AM, Hooper WD (1992) Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans. Xenobiotica 22: 385–394
Tsaconas C, Padieu P, d’Athis P, Mocaer E, Bromet N (1989) Gas chromatographicmass spectrometric assessment of the pharmacokinetics of amineptine and its main metabolite in volunteers with liver impairment. J Chromatogr 487: 313–329
Ung HL, Girault J, Lefebvre MA, Mignot A, Fourtillan JB (1987) Quantitative analysis of S2241 in human plasma and urine by combined gas chromatographynegative ion chemical ionization mass spectrometry: 15 month inter-day precision and accuracy validation. Biomed Environ Mass Spectrom 14: 289–293
Usansky JI, Damani LA (1992) The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites. Drug Metab Dispos 20: 64–69
Vachta J, Valter K, Siegfried B (1990) Metabolism of difebarbamate in man. Eur J Drug Metab Pharmacokinet 15: 191–198
Van Bakergem E, VanDerHoeven RA, Niessen WM, Tjaden UR, VanDerGreef J, Poon GK, McCague R (1992) On-line continuous-flow dialysis thermospray tandem mass spectrometry for quantitative screening of drugs in plasma: rogletimide. J Chromatogr 598: 189–194
Vandenheuvel WJA (1987) Use of stable isotopes in the elucidation of drug biotransformation processes. Xenobiotica 17: 397–412
Van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, DeJong APJM, Wattel E, Peters GJ, Lankelma J (1988) Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule. Cancer Res 48: 6956–6961
Vassel G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugieres L, Kalifa C, Gouyette A, Lemerle J (1990) Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res 50: 6203–6207
Villen T, Abdi YA, Ericsson O, Gustafsson LL, Sjoqvist F (1990) Determination of metrifonate and dichlorvos in whole blood using gas chromatography and gas chromatography-mass spectrometry. J Chromatogr 529: 309–317
Vyas KP, Kari PH, Pitzenberger SM, Halpin RA, Ramjit HG, Arison B, Murphy JS, Hoffman WF, Schwartz MS, Ulm EH, Duggan DE (1990) Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse. Drug Metab Dispos 18: 203–211
Wachs T, Conboy JC, Garcia F, Henion JD (1991) Liquid chromatography-mass spectrometry and related techniques via atmospheric pressure ionization. J Chromatogr Sci 29: 357–366
Walle T, Walle UK, Cowart TD, Conrad EC, Gaffney TE (1990) Pharmacokinetics and metabolism of oral doses of a 4’-methylthio derivative of propranolol in man. Xenobiotica 20: 321–331
Walsh JS, Patanella JE, Unger SE, Brouwer KR, Miwa GT (1990) The metabolism and excretion of carbovir, a carbocyclic nucleoside, in the rat. Drug Metab Dispos 18: 1084–1091
Wang-Iverson D, Arnold ME, Jemal M, Cohen Al (1992) Determination of SQ 33,600, a phosphinic acid containing HMG CoA reductase inhibitor, in human serum by high-performance liquid chromatography combined with ionspray mass spectrometry. Biol Mass Spectrom 21: 189–194
Weidolf L, Covey TR (1992) Studies on the metabolism of omeprazole in the rat using liquid chromatography/ionspray mass spectrometry and the isotope cluster technique with [34S]omeprazole. Rapid Commun Mass Spectrom 6: 192–196
Weil A, Caldwell J, Strolin–Benedetti M (1990) The metabolism and disposition of 14C-fenofibrate in human volunteers. Drug Metab Dispos 18: 115–120
Wilding IR, Davis SS, Hardy JG, Robertson CS, John VA, Powell ML, Leal M, Lloyd P, Walker SM (1991) Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers. Br J Clin Pharmacol 32: 573–579
Wong BK, Woolf TF, Chang T, Whitfield LR (1990) Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog. Drug Metab Dispos 18: 980–986
Wong FA, Lloyd JR, Graden DW (1990) The metabolism of etintidine in rat, dog, and human. Drug Metab Dispos 18: 949–953
Woolf TF, Bjorge SM, Black AE, Holmes A, Chang T (1991) Metabolism of the acyl-CoA: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Drug Metab Dispos 19: 696–702
Yamada Y, Ohashi R, Sugawara Y, Otsuka M, Takaiti O (1992) Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. ArzneimForsch Drug Res 42: 490–498
Yang JT, Adusumalli VE, Wong KK, Kucharczyk N, Sofia RD (1991) Felbamate metabolism in the rat, rabbit, and dog. Drug Metab Disposition 19: 1126–1134
Yeh SY (1990) N–depyridination and n–dedimethylaminoethylation of tripelennamine and pyrilamine in the rat. Drug Metab Disposition 18:453–461
Yeung PKF, Mosher SJ, Quilliam MA, Montague TJ (1990) Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats. Drug Metab Disposition 18: 1055–1059
Zhang K, Lepage F, Cuvier G, Astoin J, Rashed MS, Baillie TA (1990) The metabolic fate of stiripentol in the rat. Studies on cytochrome P-450-mediated methylenedioxy ring cleavage and side chain isomerism. Drug Metab Disposition 18: 794–803
Zhou H-H, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJJ (1989) Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med 320: 565–570
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Blair, I.A. (1994). Mass Spectrometry in Drug Disposition and Pharmacokinetics. In: Welling, P.G., Balant, L.P. (eds) Pharmacokinetics of Drugs. Handbook of Experimental Pharmacology, vol 110. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78680-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-78680-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78682-2
Online ISBN: 978-3-642-78680-8
eBook Packages: Springer Book Archive